Eli Lilly's Foundayo Achieves Broad U.S. Distribution Post-FDA Approval (April 1)

Following April 1 FDA accelerated approval, Eli Lilly's Foundayo (orforglipron) began LillyDirect shipments April 6, then expanded to wide pharmacy and telehealth networks mid-April. It is the first oral GLP-1 formulation unrestricted by meal, water or timing.